Users Online: 1392 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
     

    Article Cited by others

ORIGINAL ARTICLE

The BCG controversy : a reappraisal of the protective effect against tuberculosis and leprosy.

Zodpey S P

Year : 2004| Volume: 48| Issue : 2 | Page no: 70-77

   This article has been cited by
 
1 Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein
Deng, Y. and Bao, L. and Yang, X.
Microbiology and Immunology. 2011; 55(11): 798-808
[Pubmed]  [Google Scholar]
2 Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis
Sugawara, I., Sun, L., Mizuno, S., Taniyama, T.
Tuberculosis. 2009; 89(1): 62-67
[Pubmed]  [Google Scholar]
3 Recent advances in the tuberculin test and BCG vaccine
Tiroumourougane Serane, V., Srinivasan, S.
Indian Journal of Practical Pediatrics. 2007; 9(3): 203-215
[Pubmed]  [Google Scholar]
4 Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis
Sugawara, I., Li, Z., Sun, L., Udagawa, T., Taniyama, T.
Tuberculosis. 2007; 87(6): 518-525
[Pubmed]  [Google Scholar]

 

Read this article